Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation

Vaccines
Kathleen A CashmanC Schmaljohn

Abstract

Lassa virus (LASV) causes a severe, often fatal, hemorrhagic fever endemic to West Africa. Presently, there are no FDA-licensed medical countermeasures for this disease. In a pilot study, we constructed a DNA vaccine (pLASV-GPC) that expressed the LASV glycoprotein precursor gene (GPC). This plasmid was used to vaccinate guinea pigs (GPs) using intramuscular electroporation as the delivery platform. Vaccinated GPs were protected from lethal infection (5/6) with LASV compared to the controls. However, vaccinated GPs experienced transient viremia after challenge, although lower than the mock-vaccinated controls. In a follow-on study, we developed a new device that allowed for both the vaccine and electroporation pulse to be delivered to the dermis. We also codon-optimized the GPC sequence of the vaccine to enhance expression in GPs. Together, these innovations resulted in enhanced efficacy of the vaccine. Unlike the pilot study where neutralizing titers were not detected until after virus challenge, modest neutralizing titers were detected in guinea pigs before challenge, with escalating titers detected after challenge. The vaccinated GPs were never ill and were not viremic at any timepoint. The combination of the codon-optimized...Continue Reading

References

Oct 24, 1990·JAMA : the Journal of the American Medical Association·D CumminsS P Fisher-Hoch
Jan 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·S P Fisher-HochS Bauer
Jan 2, 1986·The New England Journal of Medicine·J B McCormickR Belmont-Williams
Aug 1, 1982·Infection and Immunity·P B JahrlingJ B Rhoderick
Jan 4, 1996·The New England Journal of Medicine·W M McDonnell, F K Askari
Jul 11, 2000·Journal of Virology·S P Fisher-HochJ B McCormick
Feb 15, 2001·The Pediatric Infectious Disease Journal·S A Plotkin
Oct 9, 2001·Reviews in Medical Virology·S P Fisher-Hoch, J B McCormick
Oct 19, 2001·Proceedings of the National Academy of Sciences of the United States of America·O LenzW Garten
Sep 27, 2003·Methods : a Companion to Methods in Enzymology·Kristina K PeachmanCarl R Alving
Apr 2, 2004·Expert Review of Vaccines·Susan P Fisher-Hoch, Joseph B McCormick
Nov 3, 2004·The Journal of Clinical Investigation·Michele A Kutzler, David B Weiner
Jun 24, 2005·PLoS Medicine·Thomas W GeisbertHeinz Feldmann
Sep 16, 2005·Vaccine·Torunn Elisabeth TjelleRune Kjeken
Nov 22, 2005·Expert Opinion on Drug Delivery·Hansi J Dean
Jan 18, 2006·Virology·Peter J BredenbeekIgor S Lukashevich
Sep 26, 2006·Methods : a Companion to Methods in Enzymology·Deborah H FullerConnie Schmaljohn
Apr 10, 2008·Human Vaccines·Ian J AmannaMark K Slifka
Sep 11, 2008·Nature Reviews. Genetics·Michele A Kutzler, David B Weiner
May 3, 2011·Current Opinion in Immunology·Niranjan Y Sardesai, David B Weiner
May 10, 2011·Virology Journal·Lisa E HensleyThomas W Geisbert
Sep 20, 2011·Virus Research·Rebecca J Grant-KleinConnie S Schmaljohn
Oct 15, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Barbara HasseUNKNOWN Swiss HIV Cohort Study
Dec 4, 2012·Viruses·Igor S Lukashevich

❮ Previous
Next ❯

Citations

Dec 9, 2014·Human Vaccines & Immunotherapeutics·Pierre LeblancMark C Poznansky
May 11, 2016·Biotechnology & Genetic Engineering Reviews·Michaela ŠimčíkováGabriel A Monteiro
Apr 26, 2017·Veterinary Pathology·T M BellK A Cashman
Jun 29, 2018·Human Gene Therapy Methods·Katherine SchultheisKate E Broderick
Apr 18, 2019·Clinical and Experimental Immunology·B AfroughR Hewson
May 10, 2019·Human Vaccines & Immunotherapeutics·Jingjing JiangStephanie J Ramos
Jul 2, 2019·The Journal of General Virology·Jie PeiLing Zhao
Jul 28, 2018·Frontiers in Cellular and Infection Microbiology·Stephen R WelchChristina F Spiropoulou
Oct 19, 2017·Human Vaccines & Immunotherapeutics·Kathleen A CashmanConnie S Schmaljohn
May 26, 2018·The Journal of Infectious Diseases·Markus H KainulainenChristina F Spiropoulou
Jan 1, 2014·Molecular Therapy. Methods & Clinical Development·Trevor Rf SmithKate E Broderick
May 17, 2021·Voprosy virusologii·O D PopovaA L Gintsburg

❮ Previous
Next ❯

Datasets Mentioned

BETA
AY628203.1

Methods Mentioned

BETA
PCR
immunoprecipitation
electrophoresis

Software Mentioned

GeneArt

Related Concepts

Related Feeds

Argentine Hemorrhagic Fever

Argentine hemorrhagic fever (AHF) is an endemo-epidemic disease caused by junín virus (JUNV), a member of the arenaviridae family. Discover the latest research on AHF here.